These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 23057844)

  • 1. A high frequency of MSH6 G268A polymorphism and survival association in glioblastoma.
    Pei C; Chen H; Jia X; Yan L; Zou Y; Jiang C; Jin H; Kang C; Jiang T; Ren H
    Int J Neurosci; 2013 Feb; 123(2):114-20. PubMed ID: 23057844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohort.
    Metellus P; Coulibaly B; Nanni I; Fina F; Eudes N; Giorgi R; Barrie M; Chinot O; Fuentes S; Dufour H; Ouafik L; Figarella-Branger D
    Cancer; 2009 Oct; 115(20):4783-94. PubMed ID: 19637364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation of O6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival.
    Eoli M; Menghi F; Bruzzone MG; De Simone T; Valletta L; Pollo B; Bissola L; Silvani A; Bianchessi D; D'Incerti L; Filippini G; Broggi G; Boiardi A; Finocchiaro G
    Clin Cancer Res; 2007 May; 13(9):2606-13. PubMed ID: 17473190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of the isocitrate dehydrogenase 1 single-nucleotide polymorphism rs11554137 in malignant gliomas.
    Wang XW; Boisselier B; Rossetto M; Marie Y; Idbaih A; Mokhtari K; Gousias K; Hoang-Xuan K; Delattre JY; Simon M; Labussière M; Sanson M
    Cancer; 2013 Feb; 119(4):806-13. PubMed ID: 23184331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variant of the CHEK2 gene as a prognostic marker in glioblastoma multiforme.
    Simon M; Ludwig M; Fimmers R; Mahlberg R; Müller-Erkwoh A; Köster G; Schramm J
    Neurosurgery; 2006 Nov; 59(5):1078-85; discussion 1085. PubMed ID: 17016233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative assessment of 5 methods (methylation-specific polymerase chain reaction, MethyLight, pyrosequencing, methylation-sensitive high-resolution melting, and immunohistochemistry) to analyze O6-methylguanine-DNA-methyltranferase in a series of 100 glioblastoma patients.
    Quillien V; Lavenu A; Karayan-Tapon L; Carpentier C; Labussière M; Lesimple T; Chinot O; Wager M; Honnorat J; Saikali S; Fina F; Sanson M; Figarella-Branger D
    Cancer; 2012 Sep; 118(17):4201-11. PubMed ID: 22294349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic quality of activating TERT promoter mutations in glioblastoma: interaction with the rs2853669 polymorphism and patient age at diagnosis.
    Spiegl-Kreinecker S; Lötsch D; Ghanim B; Pirker C; Mohr T; Laaber M; Weis S; Olschowski A; Webersinke G; Pichler J; Berger W
    Neuro Oncol; 2015 Sep; 17(9):1231-40. PubMed ID: 25681309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABCB1 single-nucleotide variants and survival in patients with glioblastoma treated with radiotherapy concomitant with temozolomide.
    Malmström A; Łysiak M; Åkesson L; Jakobsen I; Mudaisi M; Milos P; Hallbeck M; Fomichov V; Broholm H; Grunnet K; Poulsen HS; Bratthäll C; Strandeus M; Papagiannopoulou A; Stenmark-Askmalm M; Green H; Söderkvist P
    Pharmacogenomics J; 2020 Apr; 20(2):213-219. PubMed ID: 31624332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA-repair gene variants are associated with glioblastoma survival.
    Wibom C; Sjöström S; Henriksson R; Brännström T; Broholm H; Rydén P; Johansen C; Collatz-Laier H; Hepworth S; McKinney PA; Bethke L; Houlston RS; Andersson U; Melin BS
    Acta Oncol; 2012 Mar; 51(3):325-32. PubMed ID: 22017238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy and progression--induced O6-methylguanine-DNA methyltransferase and mismatch repair alterations in recurrent glioblastoma multiforme.
    Agarwal S; Suri V; Sharma MC; Sarkar C
    Indian J Cancer; 2015; 52(4):568-73. PubMed ID: 26960480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the CC genotype of the regulatory BCL2 promoter polymorphism (-938C>A) with better 2-year survival in patients with glioblastoma multiforme.
    El Hindy N; Bachmann HS; Lambertz N; Adamzik M; Nückel H; Worm K; Zhu Y; Sure U; Siffert W; Sandalcioglu IE
    J Neurosurg; 2011 Jun; 114(6):1631-9. PubMed ID: 21250804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics of ATP binding cassette transporter MDR1(1236C>T) gene polymorphism with glioma patients receiving Temozolomide-based chemoradiation therapy in Indian population.
    Munisamy M; Munisamy S; Kumar JP; Jose A; Thomas L; Baburaj G; Subbiah V
    Pharmacogenomics J; 2021 Apr; 21(2):262-272. PubMed ID: 33589792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The functional Aquaporin 1 -783G/C-polymorphism is associated with survival in patients with glioblastoma multiforme.
    El Hindy N; Rump K; Lambertz N; Zhu Y; Frey UH; Bankfalvi A; Siffert W; Sure U; Peters J; Adamzik M; Sandalcioglu IE
    J Surg Oncol; 2013 Dec; 108(7):492-8. PubMed ID: 24014128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in the interleukin-4 receptor gene are associated with better survival in patients with glioblastoma.
    Scheurer ME; Amirian E; Cao Y; Gilbert MR; Aldape KD; Kornguth DG; El-Zein R; Bondy ML
    Clin Cancer Res; 2008 Oct; 14(20):6640-6. PubMed ID: 18927306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SEL1L SNP rs12435998, a predictor of glioblastoma survival and response to radio-chemotherapy.
    Mellai M; Cattaneo M; Storaci AM; Annovazzi L; Cassoni P; Melcarne A; De Blasio P; Schiffer D; Biunno I
    Oncotarget; 2015 May; 6(14):12452-67. PubMed ID: 25948789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic MSH6-CXCR4-TGFB1 Feedback Loop: A Novel Therapeutic Target of Photothermal Therapy in Glioblastoma Multiforme.
    Chen Y; Liu P; Sun P; Jiang J; Zhu Y; Dong T; Cui Y; Tian Y; An T; Zhang J; Li Z; Yang X
    Theranostics; 2019; 9(5):1453-1473. PubMed ID: 30867843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanocortin Receptor-4 Gene Polymorphisms in Glioblastoma Patients Treated with Concomitant Radio-Chemotherapy.
    Pasqualetti F; Orlandi P; Simeon V; Cantarella M; Giuliani D; Di Desidero T; Gonnelli A; Delishaj D; Lombardi G; Sechi A; Sanson M; Zagonel V; Paiar F; Danesi R; Guarini S; Bocci G
    Mol Neurobiol; 2018 Feb; 55(2):1396-1404. PubMed ID: 28150230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism.
    Batista R; Cruvinel-Carloni A; Vinagre J; Peixoto J; Catarino TA; Campanella NC; Menezes W; Becker AP; de Almeida GC; Matsushita MM; Clara C; Neder L; Viana-Pereira M; Honavar M; Castro L; Lopes JM; Carvalho B; Vaz RM; Máximo V; Soares P; Sobrinho-Simões M; Reis RM; Lima J
    Int J Cancer; 2016 Jul; 139(2):414-23. PubMed ID: 26914704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the GNAS1 T393C polymorphism in patients with glioblastoma multiforme.
    El Hindy N; Lambertz N; Bachmann HS; Frey UH; Adamzik M; Zhu Y; Sure U; Siffert W; Sandalcioglu IE
    J Clin Neurosci; 2011 Nov; 18(11):1495-9. PubMed ID: 21924916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Glutathione S-Transferase P-1 (GSTP-1) rs1695 polymorphism with overall survival in glioblastoma patients treated with combined radio-chemotherapy.
    Pasqualetti F; Gonnelli A; Cantarella M; Delishaj D; Molinari A; Ortenzi V; Carbone F; Montrone S; Ursino S; Franceschi S; Morganti R; Orlandi P; Di Desidero T; Mazzanti CM; Zavaglia K; Naccarato AG; Bocci G; Paiar F
    Invest New Drugs; 2018 Apr; 36(2):340-345. PubMed ID: 28965273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.